EFTA Document EFTA01358265

From: Sent: To: CC: Subject: Vahe Stepanian 8/6/2015 11:57:59 AM Jeffrey Epstein [email protected] Daniel Sabba Ariane Dwyer- Stewart Oldfield Richard Kahn SGMO and VIPS (C) Classification: Confidential Paul Morris Jeffrey — as you may have seen, SGMO and VIAB reported earnings yesterday afternoon and this morning (respectively). Each name is down 17%+ on the back of the reports as both missed analyst expectations. Recall that you're long the following: Ticker Quantity SGMO 50,000 VIAB 5,000 Thank you, Vahe Date of Purchase 5/28/2013 6/10/2015 Cost Basis $8.44 $67.74 15910 US $ 5 aM At 11:49 Vol 1,382,929 Sangamo BioSciences Inc 1) Earnings History (ERN) Next kmouncernent Prior Announcement Avg/Implied 1 Day Move b Current Consensus (EEO) (E) 10/22/15 08/0S/15 / N.A. 11) S tech - 12) EPS GAAP 13) Sales 311 Net Income adjusted+ 15) Operating Profit 16)ERITOA 1) Earnings Trends (B4) :'7,58; 7.59 4x4 0 13,570 H 8.606 I /.390 Val 10.81211 """ Isnl 5 EstImates USD Periodicity glffiffir Source 0 2) Current Multiples Trailing 12M P/E Forward 12M P/E Est. LTG (EPS) NA. NA. NA. 2D Current Period Overview (Q3/15) AdtratrrsilUte 3) Analyst Coverage (ANR) Buy/Hole/Sell 7/0/0 Current Price 7.55 Target Price 22.00 -0.170 • 0.122 -39.73t Beat:4 Met:1 Missed:2 -0.170 -G.115 -47.8.31i Beat:4 Met:1 Missed:2 8.358M 14.600M -42,75%i Beat:4 Met:0 Missed:3 -12.12611 -8.286M -48,34% Beat:4 Met:0 Missed:3 4.65514 -8.00011 • Q2s Only 51 Estimate Revision Charting (EEG) faf'ea ft tat 141~ a 164 ihatat Beat 4 of 8 Beat 7 of 8 Beat 5 of 5 Kr slice • . CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) CONFIDENTIAL DB-SDNY-0045758 SDNY_GM_00 191942 EFTA01358265